Immunosuppression with high-dose I.V. cyclophosphamide and acth in progressive multiple sclerosis Cumulative experience in 100 patients
Carter J, Az S, Dawson D, Fallis R, Hafler D, Stazzone L, Weiner H. Immunosuppression with high-dose I.V. cyclophosphamide and acth in progressive multiple sclerosis Cumulative experience in 100 patients. Journal Of Neuroimmunology 1987, 16: 29. DOI: 10.1016/0165-5728(87)90173-1.Peer-Reviewed Original ResearchImmunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
Dawson DM, Carter JL, Hafler DA, Weiner HL. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Nuova Rivista Di Neurologia 1987, 57: 88-91. PMID: 3039645.Peer-Reviewed Original ResearchConceptsProgressive multiple sclerosisMonoclonal antibody therapyMultiple sclerosisAntibody therapyChronic progressive multiple sclerosisHigh-dose intravenous cyclophosphamideMultiple sclerosis patientsForm of treatmentLong-term controlIntravenous cyclophosphamideSclerosis patientsClinical resultsSerious toxicityImmune parametersPilot trialCyclophosphamideNervous systemSclerosisTerm controlsPatientsMonoclonal antibodiesACTHOnly small numbersTherapyAdverse effects